Trial Profile
A Phase III, Open Label Study to Investigate the Safety and Tolerability of the CollaRx Bupivacaine Implant in Patients After Pelvic, Abdominal, or Gynecologic Surgery
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Feb 2013
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Adverse reactions; Registrational
- 11 Feb 2013 New trial record